Colgate-Palmolive: Safe Play For Dividend Investors

 | Oct 30, 2020 12:34AM ET

Colgate-Palmolive (NYSE:CL) is set to report its Q3 2020 earnings today. A surging number of COVID-19 cases and uncertainty surrounding the upcoming election has the S&P 500 approaching correction territory – defined as a 10% drop.

Of course, if recent history is any guide, the market will quickly turn things around and set fresh all-time highs. But you can’t go wrong putting some of your money in a safe company, and few are safer than Colgate, a household and personal products giant.

CL shares had held up reasonably well in the early stages of the market’s pullback, but took a dive – by Colgate’s standards – yesterday.

The drop gives you an opportunity to buy CL at a discount ahead of earnings – which I expect to be solid.

h2 P&G’s Numbers Bode Well for Colgate/h2

Procter & Gamble (NYSE:PG), one of Colgate’s closest comps, released its fiscal first quarter numbers last week. Not only did P&G beat estimates for its most recent quarter, but it also raised its full-year guidance.

P&G CFO Jon Moeller said:

“We do expect that there is some stickiness to new habits that are being formed and new awareness that's been raised. It's hard for us to see in our interactions with consumers that we're going to snap back and revert to the same attitudes and the same behaviors that we had collectively pre-COVID.”

This should be music to P&G investors’ – and by extension, Colgate investors’ – ears. The pandemic-related boost that companies like P&G and Colgate have experienced is well-established. But the question has been: Will the gains stick post-pandemic? P&G thinks so. And I agree with that assessment. We’re seven months into the pandemic; that’s a lot of time to form lasting habits – and this pandemic isn’t over by a long shot.